[Thromboembolic disease of long standing with hyperfibrinogenemia. Treatment with heparin, magnesium and anti-inflammatory agent].
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D001780:Blood Coagulation Tests; D004341:Drug Evaluation; D005340:Fibrinogen; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008274:Magnesium / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D010654:Phenylbutyrates / Q000009:adverse effects / Q000627:therapeutic use*; D013923:Thromboembolism / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D010654:Phenylbutyrates; D005340:Fibrinogen; D006493:Heparin; D008274:Magnesium
Maladie thrombo-embolique au long cours avec hyper-fibrinogénémie. Traitement par héparine, magnésium et anti-inflammatoire.